Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis
Clinical trial NCT01878123 · COMPLETED
Trial details
- NCT number
- NCT01878123
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-07-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.